CASMN

Beijing CAS Microneedle Technology, Ltd. was registered in May 2018. It is a technology commercialization enterprise founded by Dr. Gao Yunhua and his research team, focusing on the research, production, and sales of polymer microneedle technology and innovative transdermal technologies. Beijing CAS Microneedle Technology, Ltd. (referred to as "CAS Microneedle Beijing Company") is located in the Biomedical Base of Daxing District, Beijing. The company operates a pilot R&D base covering more than 2,000 square meters, primarily conducting application research and technical services for microneedle and transdermal technologies in the fields of pharmaceutical formulations, medical devices, and cosmetics. It has CRO project R&D service capabilities and an annual pilot production capacity of 20 million patches. In October 2019, a subsidiary named Chongqing CAS Microneedle Technology, Ltd. (referred to as "CAS Microneedle Chongqing Company") was registered in Changshou District, Chongqing. This facility covers over 8,000 square meters and focuses on the R&D and production of innovative transdermal technology products for the medical aesthetics field. A GMP automated production line with an annual capacity of 150 million patches was constructed and officially began operations in 2021. CASMN is committed to building a world-class platform for the R&D and production of advanced polymer microneedle formulations and innovative transdermal technologies in China, aiming to provide advanced microneedle transdermal technology solutions for clients in the broader health industry.